No clinical complication was noticed during the follow up of the patients in spite of the high parasitaemia at the start of the treatment. ❋ Unknown (1991)
Nevertheless, no case of complication was noticed among our patients in spite of very high parasitaemia cases (some were as high as 80,000 parasites per cubic mm). ❋ Unknown (1991)
If we consider a parasitaemia of 1000 per cubic mm as "normal" in endemic areas during a period of high infection (raining season) as suggested by many authors ❋ Unknown (1991)
"Suma-Kala" was not as fast as chloroquine in clearing malaria parasitaemia. ❋ Unknown (1991)
More research should be done in order to improve the mode of administration of "Suma-Kala", and to increase its speed of clearance of malaria parasitaemia. ❋ Unknown (1991)
A parasitaemia of 1000 per cubic mm of finger blood smears is common among the people living in endemic areas like Selingue, and is well tolerated. ❋ Unknown (1991)
However, the difference between the mean log (parasitaemia count + 1) of the two groups was statistically significant. ❋ Unknown (1991)
Table 5: Proportions of patients with parasitaemia less than ❋ Unknown (1991)
Furthermore, the difference between the biological parameters (proportion of patients with a parasitaemia less than 1000) on one hand, and between the clinical parameters (proportion of patients with fever, headache, vomiting, nausea, shivering) on the other hand, were not statistically significant. ❋ Unknown (1991)
And also, the likely pattern of high parasitaemia in untreated malaria would be the occurrence of clinical malaria with a certain number of complications (for instance convulsions in children) and probably some cases of deafness. ❋ Unknown (1991)
The resultant parasitaemia was assessed daily on Giemsa-stained blood films. ❋ Irosoki Eslava (2010)
Combining antibodies resulted in either an additive effect on protection, with reduced peak parasitaemia and better survival, or resulted in a suppression of protection over that achieved by a single antibody alone. ❋ Irosoki Eslava (2010)
Molecular genotyping is performed in anti-malarial trials to determine whether recurrent parasitaemia after therapy represents a recrudescence (treatment failure) or new infection. ❋ Vinay Gupta (2010)
At a sufficient parasitaemia the blood was gained by heart puncture and about 20 million parasites were transferred into a naïve mouse. ❋ Unknown (2010)
Methods alpha-TTP knockout mice were infected with Plasmodium berghei NK65 or Plasmodium yoelii XL-17, parasitaemia, survival rate were monitored. ❋ Maria Herbas (2010)
Moreover, infected mice were treated with chloroquine and parasitaemia and survival rate were monitored. ❋ Maria Herbas (2010)
The minimum protective dose (MPD) for each mAb was determined, and then combinations of antibody at their MPD were investigated for their ability to control parasitaemia and promote survival in groups of mice. ❋ Irosoki Eslava (2010)
